Clinical trial designs for targeted agents

被引：10
|
作者：
Ma, BBY
Britten, CD
Siu, LL
机构：
[1] Univ Toronto, Princess Margaret Hosp, Hlth Network, Dept Med Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2002年 / 16卷 / 05期
关键词：
D O I：
10.1016/S0889-8588(02)00045-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The unique properties of contemporary targeted drugs pose major challenges for the development of anticancer therapy, necessitating modification of traditional clinical trial designs. This article discusses some of the strategies employed to evaluate these agents in the phase I to 111 setting, citing examples of some recently tested targeted agents to illustrate the advantages and disadvantages of various approaches.
引用
收藏
页码：1287 / +
页数：20
相关论文
共 50 条
  • [41] Dose-finding designs for trials of molecularly targeted agents and immunotherapies
    Chiuzan, Cody
    Shtaynberger, Jonathan
    Manji, Gulam A.
    Duong, Jimmy K.
    Schwartz, Gary K.
    Ivanova, Anastasia
    Lee, Shing M.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2017, 27 (03) : 477 - 494
  • [42] Adaptive designs for identifying optimal biological dose for molecularly targeted agents
    Zang, Yong
    Lee, J. Jack
    Yuan, Ying
    CLINICAL TRIALS, 2014, 11 (03) : 319 - 327
  • [43] Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies
    Wang, Shu
    Sayour, Elias
    Lee, Ji-Hyun
    JOURNAL OF APPLIED STATISTICS, 2023, 50 (09) : 2055 - 2078
  • [44] Why Does Every Hepatocellular Carcinoma Clinical Trial Using Molecular Targeted Agents Fail?
    Kudo, M.
    LIVER CANCER, 2012, 1 (02) : 59 - 60
  • [45] Adaptive designs: The Swiss Army knife among clinical trial designs?
    Bretz, Frank
    Gallo, Paul
    Maurer, Willi
    CLINICAL TRIALS, 2017, 14 (05) : 417 - 424
  • [46] Suitable trial designs and cohorts for preventive breast cancer agents
    Kathrin Strasser-Weippl
    Paul E. Goss
    Nature Reviews Clinical Oncology, 2013, 10 : 677 - 687
  • [47] Suitable trial designs and cohorts for preventive breast cancer agents
    Strasser-Weippl, Kathrin
    Goss, Paul E.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (12) : 677 - 687
  • [48] Clinical trial designs for prospective validation of biomarkers
    Mandrekar, SJ
    Grothey, A
    Goetz, MP
    Sargent, DJ
    AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (05) : 317 - 325
  • [49] Issues in the use of adaptive clinical trial designs
    Emerson, Scott S.
    STATISTICS IN MEDICINE, 2006, 25 (19) : 3270 - 3296
  • [50] Novel Clinical Trial Designs for Innovative Therapies
    Schellens, J. H. M.
    Beijnen, J. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (02) : 212 - 216
12345